SCHEMBL27689904

SCHEMBL27689904

NC(=NC(=O)/C=C/c1ccccc1)NCCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 1/20 0.48
▸ HTT P42858 1/20 0.47
▸ MMP1 P03956 2/20 0.44
▸ MMP2 P08253 2/20 0.44
▸ MMP9 P14780 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ HAO1 Q9UJM8 1/20 0.43
▸ PLAAT3 P53816 1/20 0.43
▸ PLAAT5 Q96KN8 1/20 0.43
▸ PLAAT2 Q9NWW9 1/20 0.43
▸ PLAAT4 Q9UL19 1/20 0.43
▸ HDAC3 O15379 2/20 0.42
▸ HDAC4 P56524 2/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ HDAC2 Q92769 2/20 0.42
▸ HDAC8 Q9BY41 2/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42
▸ MAPT P10636 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27689932 0.84 HTT (0.62) KMT2AHTTMMP1MMP2MMP9
SCHEMBL27689875 0.79 TDP1 (0.49) HTTMMP1MMP2MMP9RECQL
SCHEMBL14504234 0.78 CYP1A2 (0.62) KMT2AHTTRECQLHDAC3HDAC4
SCHEMBL3118443 0.78 CYP1A2 (0.62) KMT2AHTTRECQLHDAC3HDAC4
SCHEMBL27689878 0.78 MMP1 (0.58) KMT2AHTTMMP1MMP2MMP9
Idrocilamide SCHEMBL1171237 0.77 KMT2A (0.77) KMT2AMMP1MMP2MMP9RECQL
Idrocilamide SCHEMBL1171234 0.77 KMT2A (0.77) KMT2AMMP1MMP2MMP9RECQL
SCHEMBL1949536 0.76 MAPT (0.55) HTTMMP1MMP2MMP9RECQL
SCHEMBL27709603 0.75 EGFR (0.60) HTTMMP1MMP2MMP9RECQL
SCHEMBL27709705 0.75 TDP1 (0.52) HTTMMP1MMP2MMP9RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101111475-A Antiviral compounds and methods BIOTRON LTD (AU) 2008-01-23 — — CN disclosed
Send feedback